R Squared’s IDEAYA Biosciences IDYA Stock Holding History

R Squared’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,350	Closed	-$34.7K	–	847
2024 Q4	$34.7K	Buy	+1,350	New	+$38.2K	0.03%	645

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

R Squared's IDYA Position: Q1 2025 in Review

R Squared sold out of IDEAYA Biosciences (IDYA) in Q1 2025, closing a stake of 1,350 shares — an estimated $34.7K sold.

R Squared first reported a position in IDYA in Q4 2024 and held it in 1 quarter. The position peaked at $34.7K in Q4 2024. 207 funds tracked by Wall St. Rank hold IDYA as of Q1 2025.

R Squared reported no remaining IDEAYA Biosciences position as of Q1 2025 after selling out during the quarter.
R Squared sold 1,350 IDEAYA Biosciences shares in Q1 2025, an estimated $34.7K.
R Squared first reported a position in IDEAYA Biosciences in Q4 2024 and held it in 1 quarter.
R Squared's IDEAYA Biosciences position peaked at $34.7K in Q4 2024.
207 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.